AI-generated summary
The authors randomized 14 patients with temporomandibular dysfunction to active or placebo infrared laser (780 nm) over eight sessions, double-blind. They report significant pain improvement in the active group and an association with symptom reduction, while masticatory behavior did not differ between groups. The study is small and the abstract describes it as a phase II trial.
- Participants
- 14
- Who or what was studied
- Patients with temporomandibular dysfunction (TMD)
- Wavelengths
- 780 nm
- Limits stated in the abstract
- The abstract describes a small sample of 14 patients split into two groups, with no reported statistical detail beyond the p-value level and effect figures.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on tandfonline.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 780 nm
- Energy density (fluence)
- 105J/cm2
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Laser, Visual analogue scale, Placebo-controlled. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.